logo
Sign In
  1. Home
  2. Search
FiltersReset Filters
70 results

  • adakveo

    (crizanlizumab)
    Medication Details
    Novartis Pharmaceuticals Corporation
    Usage: ADAKVEO® is indicated for reducing the frequency of vaso-occlusive crises (VOCs) in adults and pediatric patients aged 16 and older with sickle cell disease.
    Medication Details

  • afinitor - everolimus tablet

    (Everolimus)
    Medication Details
    Novartis Pharmaceuticals Corporation
    Medication Details
    Drug Interactions

  • arranon - nelarabine injection

    (Nelarabine)
    Medication Details
    Novartis Pharmaceuticals Corporation
    Medication Details

  • arzerra - ofatumumab injection, solution

    (Ofatumumab)
    Medication Details
    Novartis Pharmaceuticals Corporation
    Medication Details
    Drug Interactions

  • azopt - brinzolamide suspension/ drops

    (Brinzolamide)
    Medication Details
    Novartis Pharmaceuticals Corporation
    Medication Details

  • beovu

    (brolucizumab)
    Medication Details
    Novartis Pharmaceuticals Corporation
    Usage: BEOVU® is indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD) and diabetic macular edema (DME).
    Medication Details
    Drug Interactions

  • betoptic s

    (betaxolol hydrochloride)
    Medication Details
    Novartis Pharmaceuticals Corporation
    Usage: BETOPTIC S (betaxolol hydrochloride ophthalmic suspension) 0.25% is indicated for lowering elevated intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension.
    Medication Details
    Drug Interactions

  • cipro

    (Ciprofloxacin Hydrochloride And Hydrocortisone)
    Medication Details
    Novartis Pharmaceuticals Corporation
    Medication Details

  • ciprodex - ciprofloxacin and dexamethasone suspension/ drops

    (Ciprofloxacin And Dexamethasone)
    Medication Details
    Novartis Pharmaceuticals Corporation
    Medication Details

  • coartem - artemether and lumefantrine tablet

    (Artemether And Lumefantrine)
    Medication Details
    Novartis Pharmaceuticals Corporation
    Medication Details
    • ...
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutCareersContact UsSecurity
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.